Bindley Bioscience Center collaborates with Bangalore-based company on COVID-19 research
Bindley Bioscience Center in Purdue University’s Discovery Park has signed an agreement with Eyestem Research Private Limited, Bangalore, India, to develop cellular platforms for COVID-19 research.
Under the agreement, Purdue investigators will use Eyestem’s human lung epithelial cell culture system provided as part of the company’s anti-COVID screening (ACS) platform to understand the molecular and pathological characteristics of the SARS-CoV-2 virus with a view to establishing a rational basis for testing potential drugs being developed at Purdue in vitro.